As of 2025-07-15, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -0.40. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 131.45 mil USD. INBX's TTM EBITDA according to its financial statements is -328.77 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 13.6x | 13.4x |
| Forward P/E multiples | 17.3x - 32.2x | 20.6x |
| Fair Price | (331.89) - 5,240.73 | 1,482.98 |
| Upside | -1545.5% - 22725.5% | 6359.0% |
| Date | EV/EBITDA |
| 2025-07-11 | -0.36 |
| 2025-07-10 | -0.33 |
| 2025-07-09 | -0.33 |
| 2025-07-08 | -0.30 |
| 2025-07-07 | -0.25 |
| 2025-07-03 | -0.18 |
| 2025-07-02 | -0.16 |
| 2025-07-01 | -0.13 |
| 2025-06-30 | -0.11 |
| 2025-06-27 | -0.12 |
| 2025-06-26 | -0.13 |
| 2025-06-25 | -0.13 |
| 2025-06-24 | -0.13 |
| 2025-06-23 | -0.12 |
| 2025-06-20 | -0.13 |
| 2025-06-18 | -0.14 |
| 2025-06-17 | -0.12 |
| 2025-06-16 | -0.12 |
| 2025-06-13 | -0.12 |
| 2025-06-12 | -0.11 |
| 2025-06-11 | -0.13 |
| 2025-06-10 | -0.15 |
| 2025-06-09 | -0.12 |
| 2025-06-06 | -0.10 |
| 2025-06-05 | -0.07 |
| 2025-06-04 | -0.07 |
| 2025-06-03 | -0.09 |
| 2025-06-02 | -0.07 |
| 2025-05-30 | -0.09 |
| 2025-05-29 | -0.10 |
| 2025-05-28 | -0.07 |
| 2025-05-27 | -0.08 |
| 2025-05-23 | -0.07 |
| 2025-05-22 | -0.06 |
| 2025-05-21 | -0.08 |
| 2025-05-20 | -0.07 |
| 2025-05-19 | -0.05 |
| 2025-05-16 | -0.05 |
| 2025-05-15 | -0.04 |
| 2025-05-14 | 0.00 |
| 2025-05-13 | -0.01 |
| 2025-05-12 | -0.03 |
| 2025-05-09 | -0.01 |
| 2025-05-08 | -0.01 |
| 2025-05-07 | -0.01 |
| 2025-05-06 | -0.05 |
| 2025-05-05 | -0.05 |
| 2025-05-02 | -0.04 |
| 2025-05-01 | -0.05 |
| 2025-04-30 | -0.05 |